Home › Multiple Sclerosis › California › Burbank
Multiple Sclerosis clinical trials in Burbank, CA
3 studies for Multiple Sclerosis are looking for participants at sites in and around Burbank (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
RecruitingObservational study
- TG Therapeutics Investigational Trial Site, West Hollywood · 7 mi away
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
RecruitingPhase 3
- Private Practice - Dr. Regina Berkovich- Site Number : 8400005, West Hollywood · 7 mi away
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
RecruitingPhase 3
- Regina Berkovich MD PhD Inc, West Hollywood · 7 mi away
About Multiple Sclerosis
Multiple sclerosis (MS) slows down or blocks messages between the brain and body. MS can be mild or severe. Learn about MS symptoms and treatment.
More about Multiple Sclerosis on MedlinePlus
Multiple Sclerosis trials in other cities
- New York City, NY17 studies
- Chicago, IL15 studies
- Boston, MA14 studies
- Washington, DC13 studies
- Cleveland, OH10 studies
- Birmingham, AL9 studies
- Aurora, CO8 studies
- Kansas City, KS8 studies
- St. Louis, MO8 studies
- San Francisco, CA8 studies
- Tampa, FL7 studies
- Dallas, TX7 studies
Other studies in Burbank
- Breast Cancer9 studies
- Non-Small Cell Lung Cancer8 studies
- Multiple Myeloma7 studies
- Prostate Cancer5 studies
- Heart Failure5 studies
- Colorectal Cancer5 studies
- Ovarian Cancer4 studies
- Metastatic Cancer4 studies
- Cardiovascular Disease4 studies
- Lung Cancer4 studies
- Colon Cancer4 studies
- Chronic Progressive Multiple Sclerosis3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.